These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30809577)

  • 1. New oral and topical approaches for the treatment of melasma.
    Grimes PE; Ijaz S; Nashawati R; Kwak D
    Int J Womens Dermatol; 2019 Feb; 5(1):30-36. PubMed ID: 30809577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melasma: an Up-to-Date Comprehensive Review.
    Ogbechie-Godec OA; Elbuluk N
    Dermatol Ther (Heidelb); 2017 Sep; 7(3):305-318. PubMed ID: 28726212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.
    Piętowska Z; Nowicka D; Szepietowski JC
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials.
    Pennitz A; Kinberger M; Avila Valle G; Passeron T; Nast A; Werner RN
    Br J Dermatol; 2022 Sep; 187(3):309-317. PubMed ID: 35290681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different therapeutic approaches in melasma: advances and limitations.
    Ghasemiyeh P; Fazlinejad R; Kiafar MR; Rasekh S; Mokhtarzadegan M; Mohammadi-Samani S
    Front Pharmacol; 2024; 15():1337282. PubMed ID: 38628650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasers, lights, and compounds for melasma in aesthetics.
    Kamal K; Heitmiller K; Christman M
    Clin Dermatol; 2022; 40(3):249-255. PubMed ID: 34838653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Melasma-Part II: Treatment.
    Cassiano DP; Espósito ACC; da Silva CN; Lima PB; Dias JAF; Hassun K; Miot LDB; Miot HA; Bagatin E
    Dermatol Ther (Heidelb); 2022 Sep; 12(9):1989-2012. PubMed ID: 35906506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
    Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Insights in Melasma and Hyperpigmentation Management.
    Huerth KA; Hassan S; Callender VD
    J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of combined treatments for melasma involving energy-based devices and proposed pathogenesis-oriented combinations.
    Mehrabi JN; Bar-Ilan E; Wasim S; Koren A; Zusmanovitch L; Salameh F; Isman Nelkenbaum G; Horovitz T; Zur E; Song Lim T; Mashiah J; Artzi O
    J Cosmet Dermatol; 2022 Feb; 21(2):461-472. PubMed ID: 33794033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation.
    Cantelli M; Ferrillo M; Granger C; Fabbrocini G
    J Cosmet Dermatol; 2022 Apr; 21(4):1523-1532. PubMed ID: 34087055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Melasma Treatments.
    Jo JY; Chae SJ; Ryu HJ
    Ann Dermatol; 2024 Jun; 36(3):125-134. PubMed ID: 38816973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of oral tranexamic acid as a novel treatment for melasma with a high benefit-risk ratio.
    Simpson J; Peng L; Ting W
    J Cosmet Dermatol; 2022 Nov; 21(11):6393-6399. PubMed ID: 35972476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melasma--updated treatments.
    Situm M; Kolić M; Bolanca Z; Ljubicić I; Misanović B
    Coll Antropol; 2011 Sep; 35 Suppl 2():315-8. PubMed ID: 22220462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melasma.
    Wu IB; Lambert C; Lotti TM; Hercogová J; Sintim-Damoa A; Schwartz RA
    G Ital Dermatol Venereol; 2012 Aug; 147(4):413-8. PubMed ID: 23007216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melasma Treatment: An Evidence-Based Review.
    McKesey J; Tovar-Garza A; Pandya AG
    Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of systemic treatments for skin lightening.
    Juhasz MLW; Levin MK
    J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.